未登录

D

Dae Hun Kim

sungkyunkwan university(skku)

H指数:23

被引数:1,875

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sputum Microbiome Based on the Etiology and Severity of Nontuberculous Mycobacterial Pulmonary Disease

基于非结核分枝杆菌肺部疾病病因和严重程度的痰液微生物组

Journal of Clinical Medicine

IF2.9

2026-03-030

OAAI

Long-term clinical course of Mycobacterium avium complex pulmonary disease patients with treatment failure

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2024-12-051

PRE

Comparison of the sputum microbiome between stable nontuberculous mycobacteria pulmonary disease patient and those requiring antibiotic treatment

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-300

PRE

Three-Dimensional Integrated Synaptic Devices Based on a Silver-Cluster Conduction Mechanism with High Thermostability

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2024-08-010

PRE

Single-cell transcriptomics by clinical course of Mycobacterium avium complex pulmonary disease

鸟分枝杆菌复杂肺部疾病临床病程的单细胞转录组学

SCIENTIFIC REPORTS

IF3.9

2024-07-083

OAAI

Comparison of the sputum microbiome between patients with stable nontuberculous mycobacterial pulmonary disease and patients requiring treatment

BMC MICROBIOLOGY

IF4.2

2024-05-183

OAAI

Outcomes of Intermittent Multidrug IV Therapy for Refractory Mycobacterium abscessus Pulmonary Disease

IF8.6

2024-02-012

PRE

Highly Reliable Performance of Flexible Synaptic Devices Based on PVP-GO QD Nanocomposites Due to the Formation of Directional Filaments

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2024-01-102

PRE

Electron Oscillation-Induced Splitting Electroluminescence from Nano-LEDs for Device-Level Encryption

ADVANCED MATERIALS

IF26.8

2023-12-0312

PRE

Changes in sputum microbiota during treatment for nontuberculous mycobacterial pulmonary disease

SCIENTIFIC REPORTS

IF3.9

2023-11-131

OAAI

Changes in sputum microbiota during treatment period in nontuberculous mycobacterial pulmonary disease

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

COMPARISON OF SPUTUM MICROBIOME DIVERSITIES IN NONTUBERCULOUS MYCOBACTERIAL PULMONARY DISEASE PATIENTS ACCORDING TO TREATMENT OUTCOMES

IF8.6

2023-10-010

OA

In Vitro Activity of Benzimidazole (SPR719) Against Clinical Isolates of Nontuberculous Mycobacteria With and Without Clarithromycin or Amikacin Resistance

ANNALS OF LABORATORY MEDICINE

IF3.9

2023-09-042

OAAI

Clinical Characteristics and Treatment Outcomes of Mycobacterium fortuitum Pulmonary Disease

MICROBIOLOGY SPECTRUM

IF3.8

2023-08-173

OAAI

Biocompatible memristive device based on an agarose@gold nanoparticle-nanocomposite layer obtained from nature for neuromorphic computing

SCIENTIFIC REPORTS

IF3.9

2023-04-2011

OAAI

Outcomes of Short-Term Tigecycline-Containing Regimens for Mycobacterium abscessus Pulmonary Disease

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2022-10-186

OA

FBXL17/spastin axis as a novel therapeutic target of hereditary spastic paraplegia

CELL AND BIOSCIENCE

IF6.2

2022-07-221

OAAI

The proliferative and multipotent epidermal progenitor cells for human skin reconstruction in vitro and in vivo

CELL PROLIFERATION

IF5.6

2022-06-207

OAAI

Relationship between Resistance to Ethambutol and Rifampin and Clinical Outcomes in Mycobacterium avium Complex Pulmonary Disease

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2022-04-196

OA

Intelligent, biomimetic, color-tunable, light-emitting artificial skin with memory function

IF17.1

2021-12-0115

PRE